PERMAX Side Effects

5336370-X | Acanthoma, Antinuclear Antibody Positive, Atrioventricular Block Complete, Cardiac Murmur, Cardiomegaly, Chondroplasty, Coronary Artery Disease, Hyperkeratosis, Interstitial Lung Disease
on May 07, 2007 Female patient from UNITED STATES , 45 years of age, was treated with Permax (View Usage). Patient experienced the following unwanted or unexpected effects: acanthoma, antinuclear antibody positive, atrioventricular block complete, cardiac murmur, cardiomegaly, chondroplasty, coronary artery disease (What is coronary artery disease?), hyperkeratosis, interstitial lung disease. Permax dosage: See Image. During the same period patient was treated with NARBALEK (View Narbalek Review and Narbalek Label ), DEPO MEDRO + LIDOCAINE (View Depo-medro + Lidocaine Review and Depo-medro + Lidocaine Label ), ULTRAM (View Ultram Review and Ultram Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5326893-1 | Sinus Bradycardia
Patient was taking Permax (View Usage). Patient had the following side effects: sinus bradycardia on Apr 24, 2007 from JAPAN Additional patient health information: Male patient , 64 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Permax dosage: See Image. During the same period patient was treated with ACINON (View Acinon Review and Acinon Label ), NEO DOPASTON (View Neo Dopaston Review and Neo Dopaston Label ), THYRADIN (View Thyradin Review and Thyradin Label ), ZANTAC (View Zantac Review and Zantac Label ), SERMION (View Sermion Review and Sermion Label ), GASCON (View Gascon Review and Gascon Label ).

5300423-2 | Bradycardia, Condition Aggravated
Adverse event was reported on Mar 26, 2007 by a Male patient taking Permax (View Usage) (Dosage: See Image) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 64 years of age, After Permax was administered, patient had the following side effects: bradycardia, condition aggravated.

5294374-X | Aortic Valve Disease, Somnolence
on Apr 10, 2007 Female patient from UNITED STATES , 58 years of age, weighting 185.0 lb, was diagnosed with dyskinesia, movement disorder (What is movement disorder?) and was treated with Permax (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve disease, somnolence. Permax dosage: 1 Tablet Daily. Patient was hospitalized.


5291395-8 | Abnormal Behaviour, Dyskinesia, Incorrect Dose Administered, Mood Swings, Paedophilia
on Mar 26, 2007 Male patient from ITALY , 62 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). Patient had the following side effects: abnormal behaviour, dyskinesia, incorrect dose administered, mood swings, paedophilia. Permax dosage: 1 Mg; Tid. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), CARBIDOPA (View Carbidopa Review and Carbidopa Label ), LEVODOPA W/BENSERAZIDE/ (View Levodopa W/benserazide/ Review and Levodopa W/benserazide/ Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ).

5281143-X | Asthenia, Blood Creatine Phosphokinase Increased, Fatigue, Vitamin B12 Decreased, Vitamin B12 Deficiency
Patient was taking Permax (View Usage). After Permax was administered, patient had the following side effects: asthenia, blood creatine phosphokinase increased, fatigue, vitamin b12 decreased, vitamin b12 deficiency on Mar 09, 2007 from JAPAN Additional patient health information: Male patient , 72 years of age, weighting 132.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Permax dosage: 125 Ug; Bid; Po. During the same period patient was treated with NAUZELIN (View Nauzelin Review and Nauzelin Label ).

5278392-3 | Gastrointestinal Haemorrhage, Neuroleptic Malignant Syndrome, Treatment Noncompliance
Adverse event was reported on Mar 09, 2007 by a Male patient taking Permax (View Usage) (Dosage: See Image) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 53 years of age, Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, neuroleptic malignant syndrome, treatment noncompliance. During the same period patient was treated with DOPS (View Dops Review and Dops Label ), MADOPAR (View Madopar Review and Madopar Label ), OXETACAINE (View Oxetacaine Review and Oxetacaine Label ), ATARAX (View Atarax Review and Atarax Label ), VITANEURIN (View Vitaneurin Review and Vitaneurin Label ), PANTOL (View Pantol Review and Pantol Label ). Patient was hospitalized.

5266722-8 | Apnoea, Autonomic Failure Syndrome, Blood Culture Positive, Bradycardia, Colon Cancer, Constipation, Depressed Level Of Consciousness, Endocarditis, Hepatic Function Abnormal
on Feb 23, 2007 Male patient from NETHERLANDS , 78 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). Patient had the following side effects: apnoea, autonomic failure syndrome, blood culture positive, bradycardia, colon cancer, constipation (What is constipation?), depressed level of consciousness, endocarditis (What is endocarditis?), hepatic function abnormal. Permax dosage: See Image. During the same period patient was treated with COMTAN (View Comtan Review and Comtan Label ), SELEGILINE HYDROCHLORIDE (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), FLUDROCORTISONE ACETATE (View Fludrocortisone Acetate Review and Fludrocortisone Acetate Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), MAALOX FAST BLOCKER (View Maalox Fast Blocker Review and Maalox Fast Blocker Label ).

5260735-8 | Apnoea, Bradycardia, Depressed Level Of Consciousness, Hyperkinesia, Hyperthermia
on Feb 09, 2007 Male patient from NETHERLANDS , 78 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). After Permax was administered, patient had the following side effects: apnoea, bradycardia, depressed level of consciousness, hyperkinesia, hyperthermia. Permax dosage: 1 Mg; Qid; 0.5 Mg;bid. During the same period patient was treated with COMTAN (View Comtan Review and Comtan Label ), SELEGILNE HYDROCHLORIDE (View Selegilne Hydrochloride Review and Selegilne Hydrochloride Label ), SYMMETREL (View Symmetrel Review and Symmetrel Label ), FLUDROCORTISONE ACETATE (View Fludrocortisone Acetate Review and Fludrocortisone Acetate Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), MAALOX FAST BLOCKER (View Maalox Fast Blocker Review and Maalox Fast Blocker Label ).

5250098-6 | Gastrointestinal Haemorrhage
Patient was taking Permax (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage on Feb 09, 2007 from JAPAN Additional patient health information: Male patient , 55 years of age, . Permax dosage: 2000 Ug;qid;po. During the same period patient was treated with DOPS (View Dops Review and Dops Label ), MADOPAR (View Madopar Review and Madopar Label ). Patient was hospitalized.

5248586-1 | Activities Of Daily Living Impaired, Biliary Tract Infection, Cholangitis, Cholecystitis, Gait Disturbance, Hepatic Function Abnormal, Oral Intake Reduced, Pneumonia, Pyelonephritis
Adverse event was reported on Feb 09, 2007 by a Female patient taking Permax (View Usage) (Dosage: 750 Ug;qd;po) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 76 years of age, Patient had the following side effects: activities of daily living impaired, biliary tract infection, cholangitis, cholecystitis, gait disturbance, hepatic function abnormal, oral intake reduced, pneumonia (What is pneumonia?), pyelonephritis. During the same period patient was treated with SYMMETREL (View Symmetrel Review and Symmetrel Label ), DOPS (View Dops Review and Dops Label ), MADOPAR (View Madopar Review and Madopar Label ). Patient was hospitalized.

5248217-0 | Hydronephrosis, Retroperitoneal Fibrosis
on Jan 26, 2007 Female patient from DENMARK , 61 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). After Permax was administered, patient had the following side effects: hydronephrosis, retroperitoneal fibrosis. Permax dosage: 3 Mg; Qd; Po. During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), ENDO LEVODOPA/CARBIDOPA (View Endo Levodopa/carbidopa Review and Endo Levodopa/carbidopa Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ).

5216925-3 | Gastrointestinal Haemorrhage
on Jan 03, 2007 Male patient from , 55 years of age, was treated with Permax (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage. Permax dosage: 2000 Ug;qid;po. During the same period patient was treated with DOPS (View Dops Review and Dops Label ), MADOPAR (View Madopar Review and Madopar Label ), LEVODOPA (View Levodopa Review and Levodopa Label ). Patient was hospitalized.

5165186-2 | Balance Disorder, Cardiac Failure, Fall, Hypotension, Loss Of Consciousness, Muscular Weakness, Pericarditis Constrictive, Post Procedural Complication, Shock
Patient was taking Permax (View Usage). Patient had the following side effects: balance disorder, cardiac failure, fall (What is fall?), hypotension, loss of consciousness, muscular weakness, pericarditis constrictive, post procedural complication, shock on Nov 14, 2006 from JAPAN Additional patient health information: Male patient , 66 years of age, weighting 114.6 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Permax dosage: 150 Ug Qd Po ; 750 Ug Qd Po. During the same period patient was treated with SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), NEO DOPASTON (View Neo Dopaston Review and Neo Dopaston Label ). Patient was hospitalized.

5129327-5 | Hydronephrosis, Retroperitoneal Fibrosis
Adverse event was reported on Sep 29, 2006 by a Female patient taking Permax (View Usage) (Dosage: 3 Mg; Qd; Po) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: DENMARK , 61 years of age, weighting 154.3 lb, After Permax was administered, patient had the following side effects: hydronephrosis, retroperitoneal fibrosis. During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), ENDO LEVODOPA/CARBIDOPA (View Endo Levodopa/carbidopa Review and Endo Levodopa/carbidopa Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ).

5115330-8 | Balance Disorder, Fall, Gait Disturbance, Loss Of Consciousness, Muscular Weakness, Pericarditis Constrictive, Post Procedural Complication, Stress
on Sep 08, 2006 Male patient from JAPAN , 66 years of age, weighting 114.6 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). Patient experienced the following unwanted or unexpected effects: balance disorder, fall (What is fall?), gait disturbance, loss of consciousness, muscular weakness, pericarditis constrictive, post procedural complication, stress (What is stress?). Permax dosage: See Image. During the same period patient was treated with SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), NEO DOPASTON (View Neo Dopaston Review and Neo Dopaston Label ). Patient was hospitalized.

5106921-9 | Abnormal Behaviour, Anaemia, Breast Cyst, Endocarditis, Foot Fracture, Gambling, Hand Fracture, Marital Problem
on Aug 29, 2006 Female patient from UNITED STATES , 42 years of age, weighting 238.0 lb, was diagnosed with muscle twitching and was treated with Permax (View Usage). Patient had the following side effects: abnormal behaviour, anaemia, breast cyst, endocarditis (What is endocarditis?), foot fracture, gambling, hand fracture, marital problem. Permax dosage: 0.05 Mg; See Image. During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ). Patient was hospitalized.

5090942-9 | Anaemia, Anxiety, Aortic Valve Sclerosis, Breast Cyst, Cardiac Hypertrophy, Depression, Dilatation Atrial, Dizziness
Patient was taking Permax (View Usage). After Permax was administered, patient had the following side effects: anaemia, anxiety (What is anxiety?), aortic valve sclerosis, breast cyst, cardiac hypertrophy, depression (What is depression?), dilatation atrial, dizziness (What is dizziness?) on Aug 09, 2006 from UNITED STATES Additional patient health information: Female patient , 42 years of age, weighting 238.0 lb, was diagnosed with muscle twitching and. Permax dosage: See Image. During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ). Patient was hospitalized.

5084868-4 | Atrial Fibrillation, Basedow's Disease, Blood Creatine Phosphokinase Increased, Congestive Cardiomyopathy, Depressed Level Of Consciousness, Diabetes Mellitus, Dyspnoea, Ejection Fraction Decreased, Neuroleptic Malignant Syndrome
Adverse event was reported on Aug 04, 2006 by a Male patient taking Permax (View Usage) (Dosage: See Image) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), basedow's disease, blood creatine phosphokinase increased, congestive cardiomyopathy, depressed level of consciousness, diabetes mellitus, dyspnoea, ejection fraction decreased, neuroleptic malignant syndrome. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), SELEGILINE HYDROCHLORIDE (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ). Patient was hospitalized.

5079641-7 | Balance Disorder, Fall, Loss Of Consciousness, Pericarditis Constrictive
on Jul 24, 2006 Male patient from JAPAN , 66 years of age, weighting 114.6 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). Patient had the following side effects: balance disorder, fall (What is fall?), loss of consciousness, pericarditis constrictive. Permax dosage: 750 Ug; Qd; Po. During the same period patient was treated with SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), NEO DOPASTON (View Neo Dopaston Review and Neo Dopaston Label ). Patient was hospitalized.

5079296-1 | Abasia, Activities Of Daily Living Impaired, Aggression, Agitation, Cognitive Disorder, Condition Aggravated, Cyclothymic Disorder, Delusion, Dementia
on Jul 24, 2006 Male patient from UNITED STATES , 69 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?), psychotic disorder (What is psychotic disorder?) and was treated with Permax (View Usage). After Permax was administered, patient had the following side effects: abasia, activities of daily living impaired, aggression, agitation, cognitive disorder, condition aggravated, cyclothymic disorder, delusion, dementia (What is dementia?). Permax dosage: . During the same period patient was treated with CARBIDOPA (View Carbidopa Review and Carbidopa Label ), LEVODOPA (View Levodopa Review and Levodopa Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), ZIPRASIDONE HCL (View Ziprasidone Hcl Review and Ziprasidone Hcl Label ), QUETIAPINE FUMARATE (See Image) (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ). Patient was hospitalized.

5072789-2 | Atrial Fibrillation, Basedow's Disease, Blood Creatine Phosphokinase Increased, Congestive Cardiomyopathy, Depressed Level Of Consciousness, Diabetes Mellitus, Dyspnoea, Ejection Fraction Decreased, Neuroleptic Malignant Syndrome
Patient was taking Permax (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), basedow's disease, blood creatine phosphokinase increased, congestive cardiomyopathy, depressed level of consciousness, diabetes mellitus, dyspnoea, ejection fraction decreased, neuroleptic malignant syndrome on Jul 19, 2006 from JAPAN Additional patient health information: Male patient , 64 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Permax dosage: 1750 Ug;qd;po. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), SELEGILINE HYDROCHLORIDE (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ), ..................... (View ..................... Review and ..................... Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), ....................... (View ....................... Review and ....................... Label ). Patient was hospitalized.

5066258-3 | Abnormal Behaviour, Anaemia, Anxiety, Aortic Valve Sclerosis, Breast Cyst, Cardiac Hypertrophy, Cardiac Ventricular Disorder, Depression, Dilatation Atrial
Adverse event was reported on Jul 13, 2006 by a Female patient taking Permax (View Usage) (Dosage: See Image) was diagnosed with muscle twitching and. Location: UNITED STATES , 42 years of age, weighting 238.0 lb, Patient had the following side effects: abnormal behaviour, anaemia, anxiety (What is anxiety?), aortic valve sclerosis, breast cyst, cardiac hypertrophy, cardiac ventricular disorder, depression (What is depression?), dilatation atrial. During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

5065158-2 | Anxiety, Cardiomyopathy, Chest Pain, Depressed Mood, Depression, Gait Disturbance, Insomnia
on Jul 10, 2006 Female patient from JAPAN , 76 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). After Permax was administered, patient had the following side effects: anxiety (What is anxiety?), cardiomyopathy (What is cardiomyopathy?), chest pain (What is chest pain?), depressed mood, depression (What is depression?), gait disturbance, insomnia. Permax dosage: See Image. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), DOPS (View Dops Review and Dops Label ), TOLEDOMIN (View Toledomin Review and Toledomin Label ). Patient was hospitalized.

5055299-8 | Cardiac Disorder, Condition Aggravated, Depressed Level Of Consciousness, Neuroleptic Malignant Syndrome
on Jul 05, 2006 Male patient from JAPAN , 64 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac disorder, condition aggravated, depressed level of consciousness, neuroleptic malignant syndrome. Permax dosage: 1750 Ug; Qd; Po. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), SELEGILINE HYDROCHLORIDE (View Selegiline Hydrochloride Review and Selegiline Hydrochloride Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ). Patient was hospitalized.

5036222-9 | Aortic Valve Incompetence, Aortic Valve Stenosis, Mitral Valve Incompetence, Mitral Valve Stenosis, Pulmonary Hypertension
Patient was taking Permax (View Usage). Patient had the following side effects: aortic valve incompetence, aortic valve stenosis, mitral valve incompetence, mitral valve stenosis, pulmonary hypertension (What is pulmonary hypertension?) on Mar 07, 2005 from UNITED STATES Additional patient health information: Female patient , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Permax dosage: 1 Mg;tid;po. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ).

5036221-7 | Sinus Arrhythmia, Tachycardia
Adverse event was reported on Dec 02, 2005 by a Male patient taking Permax (View Usage) (Dosage: 0.05 Mg;qd;po) was diagnosed with tourette's disorder and. Location: UNITED STATES , child 12 years of age, After Permax was administered, patient had the following side effects: sinus arrhythmia, tachycardia.

5036215-1 | Parkinsonism, Pleural Effusion, Pulmonary Fibrosis
on Sep 02, 2005 Male patient from UNITED STATES , 55 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). Patient experienced the following unwanted or unexpected effects: parkinsonism, pleural effusion, pulmonary fibrosis (What is pulmonary fibrosis?). Permax dosage: 1.5 Mg;qd. During the same period patient was treated with BROMOCRIPTINE MESYLATE (View Bromocriptine Mesylate Review and Bromocriptine Mesylate Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), LEVODOPA (View Levodopa Review and Levodopa Label ), CARBIDOPA (View Carbidopa Review and Carbidopa Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ).

5011579-3 | Anxiety, Depression, Insomnia, Marital Problem, Pathological Gambling, Suicidal Ideation
on May 09, 2006 Female patient from UNITED STATES , 42 years of age, weighting 238.0 lb, was diagnosed with muscle twitching and was treated with Permax (View Usage). Patient had the following side effects: anxiety (What is anxiety?), depression (What is depression?), insomnia, marital problem, pathological gambling, suicidal ideation. Permax dosage: See Image. During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

4991189-4 | Anaemia, C-reactive Protein Increased, Chest X-ray Abnormal, Fatigue, Haemoglobin Decreased, Hydronephrosis, Laboratory Test Abnormal, Lymphoedema, Nuclear Magnetic Resonance Imaging Abnormal
Patient was taking Permax (View Usage). After Permax was administered, patient had the following side effects: anaemia, c-reactive protein increased, chest x-ray abnormal, fatigue, haemoglobin decreased, hydronephrosis, laboratory test abnormal, lymphoedema, nuclear magnetic resonance imaging abnormal on Apr 13, 2006 from DENMARK Additional patient health information: Male patient , 69 years of age, weighting 187.6 lb, was diagnosed with dystonia (What is dystonia?), restless legs syndrome and. Permax dosage: 1 Mg; Qid; Po. During the same period patient was treated with EFFEXOR (View Effexor Review and Effexor Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), SINALFA (View Sinalfa Review and Sinalfa Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), HERBAL PREPARATION (View Herbal Preparation Review and Herbal Preparation Label ). Patient was hospitalized.

4985026-1 | Delirium, Excitability, Fracture, Hallucination, Insomnia, Stress
Adverse event was reported on Apr 12, 2006 by a Male patient taking Permax (View Usage) (Dosage: 1500 Ug; Po) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 55 years of age, Patient experienced the following unwanted or unexpected effects: delirium, excitability, fracture (What is fracture?), hallucination, insomnia, stress (What is stress?). During the same period patient was treated with SINEMET (150 Mg; Po) (View Sinemet Review and Sinemet Label ). Patient was hospitalized.

4983752-1 | Aortic Valve Incompetence, Aortic Valve Stenosis, Mitral Valve Incompetence, Mitral Valve Stenosis, Pulmonary Hypertension
on Mar 07, 2005 Female patient from UNITED STATES , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). Patient had the following side effects: aortic valve incompetence, aortic valve stenosis, mitral valve incompetence, mitral valve stenosis, pulmonary hypertension (What is pulmonary hypertension?). Permax dosage: 1 Mg;tid;po. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ).

4983751-X | Sinus Arrhythmia, Tachycardia
on Dec 02, 2005 Male patient from UNITED STATES , child 12 years of age, was diagnosed with tourette's disorder and was treated with Permax (View Usage). After Permax was administered, patient had the following side effects: sinus arrhythmia, tachycardia. Permax dosage: 0.05 Mg;qd;po.

4983748-X | Parkinsonism, Pleural Effusion, Pulmonary Fibrosis
Patient was taking Permax (View Usage). Patient experienced the following unwanted or unexpected effects: parkinsonism, pleural effusion, pulmonary fibrosis (What is pulmonary fibrosis?) on Sep 02, 2005 from UNITED STATES Additional patient health information: Male patient , 55 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Permax dosage: 1.5 Mg;qd. During the same period patient was treated with BROMOCRIPTINE MESYLATE (View Bromocriptine Mesylate Review and Bromocriptine Mesylate Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), LEVODOPA (View Levodopa Review and Levodopa Label ), CARBIDOPA (View Carbidopa Review and Carbidopa Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ).

4981235-6 | Anxiety, Aortic Valve Sclerosis, Cardiac Function Disturbance Postoperative, Cardiac Hypertrophy, Compulsions, Depression, Dilatation Atrial, Dizziness
Adverse event was reported on Apr 03, 2006 by a Female patient taking Permax (View Usage) (Dosage: See Image) was diagnosed with muscle twitching and. Location: UNITED STATES , 42 years of age, Patient had the following side effects: anxiety (What is anxiety?), aortic valve sclerosis, cardiac function disturbance postoperative, cardiac hypertrophy, compulsions, depression (What is depression?), dilatation atrial, dizziness (What is dizziness?). During the same period patient was treated with WELLBUTRIN SLOW (View Wellbutrin - Slow Review and Wellbutrin - Slow Label ), RELEASE (View Release Review and Release Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ). Patient was hospitalized.

4978883-6 | Blood Albumin Decreased, Blood Creatine Phosphokinase Increased, Blood Sodium Decreased, Cardiovascular Disorder, Decreased Appetite, Disseminated Intravascular Coagulation, Malnutrition, Multi-organ Failure, Pneumonia
on Sep 21, 2005 Male patient from JAPAN , 87 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). After Permax was administered, patient had the following side effects: blood albumin decreased, blood creatine phosphokinase increased, blood sodium decreased, cardiovascular disorder, decreased appetite, disseminated intravascular coagulation, malnutrition, multi-organ failure, pneumonia (What is pneumonia?). Permax dosage: 1000 Ug; Qd; Po. During the same period patient was treated with SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), ............ (View ............ Review and ............ Label ), CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), DROXIDOPA (View Droxidopa Review and Droxidopa Label ). Patient was hospitalized.

4931439-3 | Angina Unstable, Anxiety, Aortic Valve Incompetence, Atrial Fibrillation, Cardiac Failure Congestive, Cardiac Stress Test Abnormal, Cardiac Valve Disease, Chest Pain, Coronary Artery Disease
on Nov 29, 2005 Male patient from UNITED STATES , 73 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). Patient experienced the following unwanted or unexpected effects: angina unstable, anxiety (What is anxiety?), aortic valve incompetence, atrial fibrillation (What is atrial fibrillation?), cardiac failure congestive, cardiac stress test abnormal, cardiac valve disease, chest pain (What is chest pain?), coronary artery disease (What is coronary artery disease?). Permax dosage: . During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), COMTAN (View Comtan Review and Comtan Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ). Patient was hospitalized.

4931022-X | Lymphadenopathy Mediastinal, Pleural Fibrosis, Pulmonary Arterial Pressure Increased, Pulmonary Fibrosis, Restrictive Pulmonary Disease, Rosai-dorfman Syndrome, Tricuspid Valve Incompetence
Patient was taking Permax (View Usage). Patient had the following side effects: lymphadenopathy mediastinal, pleural fibrosis, pulmonary arterial pressure increased, pulmonary fibrosis (What is pulmonary fibrosis?), restrictive pulmonary disease, rosai-dorfman syndrome, tricuspid valve incompetence on Sep 01, 2005 from DENMARK Additional patient health information: Male patient , 64 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Permax dosage: 1 Mg;tid;po. During the same period patient was treated with ELDEPRYL (View Eldepryl Review and Eldepryl Label ), SINEMET (View Sinemet Review and Sinemet Label ), APURIN (View Apurin Review and Apurin Label ), BERODUAL (View Berodual Review and Berodual Label ).

4931020-6 | Aortic Valve Disease, Cardiac Failure, Condition Aggravated, Dyspnoea Exertional, Pulmonary Arterial Pressure Increased
Adverse event was reported on Aug 24, 2005 by a Female patient taking Permax (View Usage) (Dosage: 6 Mg;qd;po) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: FRANCE , 64 years of age, After Permax was administered, patient had the following side effects: aortic valve disease, cardiac failure, condition aggravated, dyspnoea exertional, pulmonary arterial pressure increased. During the same period patient was treated with MODOPAR (View Modopar Review and Modopar Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), CALCIDOSE (View Calcidose Review and Calcidose Label ).

4930926-1 | Anxiety, Compulsions, Depression, Feeling Guilty, Insomnia, Marital Problem, Obsessive-compulsive Disorder, Pathological Gambling
on Jul 18, 2005 Female patient from UNITED STATES , 42 years of age, was diagnosed with muscle twitching and was treated with Permax (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), compulsions, depression (What is depression?), feeling guilty, insomnia, marital problem, obsessive-compulsive disorder (What is obsessive-compulsive disorder?), pathological gambling. Permax dosage: 2 Mg;qd. Patient was hospitalized.

4930924-8 | Alopecia, Anaemia, Angina Pectoris, Aortic Valve Incompetence, Cardiac Failure Congestive, Cardiac Valve Disease, Cardiomyopathy, Cardiovascular Disorder, Catheterisation Cardiac
on Aug 23, 2005 Female patient from UNITED STATES , 78 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). Patient had the following side effects: alopecia, anaemia, angina pectoris, aortic valve incompetence, cardiac failure congestive, cardiac valve disease, cardiomyopathy (What is cardiomyopathy?), cardiovascular disorder, catheterisation cardiac. Permax dosage: 7.5 Mg;qd. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ), PRIMIDONE (View Primidone Review and Primidone Label ), ZESTRIL (View Zestril Review and Zestril Label ), CLYCERYL TRINITRATE (View Clyceryl Trinitrate Review and Clyceryl Trinitrate Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), ARTANE (View Artane Review and Artane Label ), SINEMET (View Sinemet Review and Sinemet Label ). Patient was hospitalized.

4930738-9 | Anxiety, Aortic Valve Incompetence, Atrial Fibrillation, Cardiac Failure Congestive, Chest Pain, Colonic Polyp, Contusion, Coordination Abnormal, Coronary Artery Disease
Patient was taking Permax (View Usage). After Permax was administered, patient had the following side effects: anxiety (What is anxiety?), aortic valve incompetence, atrial fibrillation (What is atrial fibrillation?), cardiac failure congestive, chest pain (What is chest pain?), colonic polyp (What is colonic polyp?), contusion, coordination abnormal, coronary artery disease (What is coronary artery disease?) on Nov 02, 2005 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Permax dosage: 4 Mg;qd. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), ATIVAN (View Ativan Review and Ativan Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), PREMARIN (View Premarin Review and Premarin Label ), PAXIL (View Paxil Review and Paxil Label ). Patient was hospitalized and became disabled.

4930737-7 | Aortic Valve Incompetence, Aortic Valve Sclerosis, Cardiac Valve Disease, Cholelithiasis, Mitral Valve Incompetence, Mitral Valve Sclerosis, Nightmare, Sleep Apnoea Syndrome
Adverse event was reported on Dec 01, 2004 by a Male patient taking Permax (View Usage) (Dosage: See Image) was diagnosed with restless legs syndrome and. Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: aortic valve incompetence, aortic valve sclerosis, cardiac valve disease, cholelithiasis, mitral valve incompetence, mitral valve sclerosis, nightmare, sleep apnoea syndrome. During the same period patient was treated with KLONOPIN (View Klonopin Review and Klonopin Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), NEURONTIN (View Neurontin Review and Neurontin Label ).

4930731-6 | Abdominal Pain, Anxiety, Aortic Valve Incompetence, Back Pain, Cardiac Valve Disease, Chest Pain, Chordae Tendinae Rupture, Coronary Artery Disease, Dilatation Atrial
on Mar 21, 2005 Female patient from UNITED STATES , 55 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anxiety (What is anxiety?), aortic valve incompetence, back pain (What is back pain?), cardiac valve disease, chest pain (What is chest pain?), chordae tendinae rupture, coronary artery disease (What is coronary artery disease?), dilatation atrial. Permax dosage: See Image. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PREMARIN (View Premarin Review and Premarin Label ), TOCOPHERYL ACETATE (View Tocopheryl Acetate Review and Tocopheryl Acetate Label ).

4930725-0 | Anxiety, Aortic Valve Incompetence, Aortic Valve Stenosis, Arrhythmia, Arrhythmia Supraventricular, Asthenia, Cardiac Murmur, Cardiac Valve Disease, Cellulitis
on Sep 29, 2005 Female patient from UNITED STATES , 56 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). After Permax was administered, patient had the following side effects: anxiety (What is anxiety?), aortic valve incompetence, aortic valve stenosis, arrhythmia (What is arrhythmia?), arrhythmia supraventricular, asthenia, cardiac murmur, cardiac valve disease, cellulitis (What is cellulitis?). Permax dosage: See Image. During the same period patient was treated with HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), COGENTIN (View Cogentin Review and Cogentin Label ), LASIX (View Lasix Review and Lasix Label ), ELDEPRYL (View Eldepryl Review and Eldepryl Label ), ULTRAVATE (View Ultravate Review and Ultravate Label ). Patient was hospitalized.

4930719-5 | Aortic Arteriosclerosis, Aortic Valve Incompetence, Arthralgia, Cardiac Valve Disease, Cardiomegaly, Carpal Tunnel Decompression, Cerebellar Infarction, Cerebral Infarction, Condition Aggravated
Patient was taking Permax (View Usage). Patient experienced the following unwanted or unexpected effects: aortic arteriosclerosis, aortic valve incompetence, arthralgia, cardiac valve disease, cardiomegaly, carpal tunnel decompression, cerebellar infarction, cerebral infarction, condition aggravated on Nov 17, 2005 from UNITED STATES Additional patient health information: Female patient , 69 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Permax dosage: See Image. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), SINEMET (View Sinemet Review and Sinemet Label ), COMTAN (View Comtan Review and Comtan Label ), NOLVADEX (View Nolvadex Review and Nolvadex Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ). Patient was hospitalized.

4863271-3 | Cardiac Valve Disease
Adverse event was reported on Dec 19, 2005 by a Female patient taking Permax (View Usage) (Dosage: .025 - .0375 Daily) was diagnosed with restless legs syndrome and. Location: UNITED STATES , weighting 185.0 lb, Patient had the following side effects: cardiac valve disease.

4845060-9 | Mitral Valve Replacement, Tricuspid Valve Disease, Triple Vessel Bypass Graft
on Dec 02, 2005 Female patient from UNITED STATES , weighting 180.0 lb, was diagnosed with restless legs syndrome and was treated with Permax (View Usage). After Permax was administered, patient had the following side effects: mitral valve replacement, tricuspid valve disease, triple vessel bypass graft. Permax dosage: .025 To .0375 Daily For 6 Years.

4831111-4 | Hallucination, Visual, Neuroleptic Malignant Syndrome
on Oct 21, 2005 Male patient from JAPAN , 79 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Permax (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, visual, neuroleptic malignant syndrome. Permax dosage: 500 Ug; Daily; Oral ; 750 Ug; Daily Oral. During the same period patient was treated with NEODOPASOL (View Neodopasol Review and Neodopasol Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ). Patient was hospitalized.

4745488-1 | Aortic Valve Incompetence, Aortic Valve Sclerosis, Aortic Valve Stenosis, Atrial Fibrillation, Atrioventricular Block Complete, Bone Density Decreased, Cardiac Failure, Cardiomegaly, Cardiomyopathy
Patient was taking Permax (View Usage). Patient had the following side effects: aortic valve incompetence, aortic valve sclerosis, aortic valve stenosis, atrial fibrillation (What is atrial fibrillation?), atrioventricular block complete, bone density decreased, cardiac failure, cardiomegaly, cardiomyopathy (What is cardiomyopathy?) on Jul 26, 2005 from UNITED STATES Additional patient health information: Female patient , 50 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Permax dosage: .05 Mg; 3 Times A Day;see Image. During the same period patient was treated with ...... (View ...... Review and ...... Label ), SINEMET (View Sinemet Review and Sinemet Label ), TIGAN (View Tigan Review and Tigan Label ). Patient was hospitalized.